Better glycaemic control with BioChaperone glargine lispro co‐formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes-Reference-Cited by-同舟云学术

Better glycaemic control with BioChaperone glargine lispro co‐formulation than with insulin lispro Mix25 or separate glargine and lispro administrations after a test meal in people with type 2 diabetes

Published:2019-04-08 Issue:7 Volume:21 Page:1570-1575
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Meiffren Grégory¹,Herbrand Theresa²,Anastassiadis Ernestos³,Klein Oliver²,DeVries J. Hans²^ORCID,Heise Tim²^ORCID,Alluis Bertrand¹,Mégret Claire¹,Gaudier Martin¹,Soula Olivier¹,Plum‐Mörschel Leona³

Affiliation:

1. Adocia Lyon France

2. Profil Neuss Germany

3. Profil Mainz Germany

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13685

Reference8 articles.

1. Early Pharmacokinetic and Pharmacodynamic Effects of Mixing Lispro With Glargine Insulin

2. Defining and Reporting Hypoglycemia in Diabetes

3. Pharmacodynamic (PD) profile of BioChaperone® combo (BC combo), a new combination rapid‐acting and long‐acting insulin, in subjects with type 2 diabetes mellitus (T2DM);Hoevelmann U;Diabetes,2016

4. Insulin Aspart in a 30/70 Premixed Formulation: Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture

5. Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future directions in insulin therapy;Metabolism;2021-11

2. Pre-mixed insulin has a similar efficacy to basal-bolus insulin in reducing HbA1c levels in type 2 diabetics;Clinical Research In Practice: The Journal of Team Hippocrates;2021-10-13

3. Insulin therapy development beyond 100 years;The Lancet Diabetes & Endocrinology;2021-10

4. Recent Advances in Insulin Therapy;Diabetes Technology & Therapeutics;2020-12-01